Pricing

Arovella Therapeutics ASX: ALA

0 followers

‌

Biotechnology, cell therapy, oncology, iNKT cell therapy, invariant natural killer T (iNKT) cell therapy platform, blood cancers, solid tumours, gastric & pancreatic cancers.

Industries

Biotechnology, Life Sciences

Employees

11-50

Links

Org chart

Michael Baker

CEO & Managing Director

Collapse

Robson Dossa

Vice President - Manufacturing And Quality

Nicole van der Weerden

Chief Operating Officer

Debora Barton

Clinical Advisory Board

Teams

This company has no teams yet

Offices

This company has no offices yet